CN107050059A - 脚气灵纳米乳膏 - Google Patents
脚气灵纳米乳膏 Download PDFInfo
- Publication number
- CN107050059A CN107050059A CN201710165313.6A CN201710165313A CN107050059A CN 107050059 A CN107050059 A CN 107050059A CN 201710165313 A CN201710165313 A CN 201710165313A CN 107050059 A CN107050059 A CN 107050059A
- Authority
- CN
- China
- Prior art keywords
- emulsifiable paste
- jiaoqiling
- beriberi
- nanometer
- tinea pedis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010047601 Vitamin B1 deficiency Diseases 0.000 title claims abstract description 20
- 208000002894 beriberi Diseases 0.000 title claims abstract description 20
- 201000004647 tinea pedis Diseases 0.000 claims abstract description 21
- 208000002474 Tinea Diseases 0.000 claims abstract description 15
- 210000002683 foot Anatomy 0.000 claims abstract description 14
- 241000893966 Trichophyton verrucosum Species 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 9
- 201000004624 Dermatitis Diseases 0.000 claims abstract description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000001737 promoting effect Effects 0.000 claims abstract description 8
- 241000555745 Sciuridae Species 0.000 claims abstract description 7
- 241000130764 Tinea Species 0.000 claims abstract description 7
- 230000001139 anti-pruritic effect Effects 0.000 claims abstract description 7
- 239000003908 antipruritic agent Substances 0.000 claims abstract description 7
- 241000241413 Propolis Species 0.000 claims abstract description 6
- 240000004980 Rheum officinale Species 0.000 claims abstract description 6
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 6
- 239000005864 Sulphur Substances 0.000 claims abstract description 6
- 239000006071 cream Substances 0.000 claims abstract description 6
- 229940069949 propolis Drugs 0.000 claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 6
- 241000258920 Chilopoda Species 0.000 claims abstract description 5
- 208000003251 Pruritus Diseases 0.000 claims abstract description 5
- 244000195896 dadap Species 0.000 claims abstract description 5
- 238000005469 granulation Methods 0.000 claims abstract description 5
- 230000003179 granulation Effects 0.000 claims abstract description 5
- 230000017074 necrotic cell death Effects 0.000 claims abstract description 5
- 240000000233 Melia azedarach Species 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 241000623906 Lytta vesicatoria Species 0.000 claims description 5
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 claims description 4
- YEXPOXQUZXUXJW-UHFFFAOYSA-N lead(II) oxide Inorganic materials [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 claims description 4
- 210000000481 breast Anatomy 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 206010017533 Fungal infection Diseases 0.000 abstract description 7
- 208000031888 Mycoses Diseases 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 201000010618 Tinea cruris Diseases 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- 239000007908 nanoemulsion Substances 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 208000017520 skin disease Diseases 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 19
- 239000003814 drug Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 3
- 206010067197 Tinea manuum Diseases 0.000 description 3
- 229940116229 borneol Drugs 0.000 description 3
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 3
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 241000931705 Cicada Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- -1 chromocor compound Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 229910052957 realgar Inorganic materials 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241001645380 Bassia scoparia Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000592274 Polypodium vulgare Species 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- 206010048625 Skin maceration Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 230000000629 anti-dermatophyte Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 210000004082 barrier epithelial cell Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000004890 epithelial barrier function Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 208000005005 intertrigo Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940101209 mercuric oxide Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Animal Husbandry (AREA)
- Marine Sciences & Fisheries (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种脚气灵纳米乳膏,是属于精细化工小产品脚气灵纳米乳膏配制生产技术领域。是由所述旱獭油蜈蚣用于脚气脚臭类皮肤病乳膏,木槿皮蜂胶用于手足股体癣杀菌止痒乳膏,硫磺大黄杀菌除湿化腐生肌除脚气乳膏,川楝皮海桐皮用于治疗久治不愈的顽癣手足癣乳膏组成。脚癣是皮肤的浅部真菌感染性皮肤病,反复发作,不易治愈,本品用纳米化粉碎的纳米乳以保全天然植物功效和全部营养成分为主;以渗透性强,吸收快,抗菌消炎,去湿止痒,排毒祛湿,消炎生肌,防止真菌感染,治手,足,头,体,股癣顽癣,起效快,疗程短,效果显著,不易复发的天然植物脚气灵纳米乳膏。
Description
技术领域:
本发明公开了一种脚气灵纳米乳膏,是属于化工小产品配制生产技术领域。
背景技术:
脚气即脚癣是皮肤的浅部真菌感染。病原菌为红色毛癣菌、絮状表皮菌及须毛癣菌。多为间接感染,如用公共浴盆及拖鞋。临床分为水疱型、鳞屑角化型、浸渍型。初期见成群或散在针头大水疱,不易破裂,干燥后疱顶表皮脱落,形成环状鳞屑,新的损害相继出现,互相融合,形成多环状等,即为水疱型。以脱屑,角质增厚,皮肤粗糙干燥为主要表现者,即为鳞屑角化型。指(趾)间皮肤浸渍发白,常因剧痒掻抓摩擦后而引起表皮擦烂,露出潮红糜面等,即为浸渍型。
西医常针对不同临床类型采用相应的外治方法,内服药主要有酮康唑等。中医对手癣有“鹅掌风”,足癣“脚湿气”之称,认为多系外受风毒,内为血燥,凝集皮肤而致。治以清热利湿解毒,内服外治相结合。
发明内容:
本发明的目的在于提供一种脚气灵纳米乳膏。
本发明的技术解决方案是:
1、一种脚气灵纳米乳膏,其特征是,所述旱獭油蜈蚣用于脚气脚臭类皮肤病乳膏,按下列质量份配比组成%
制备方法:
首先旱獭油的制备方法是:将家养的活旱獭处死后,取材进行鼠疫细菌学实验,阴性者,剥皮取油提炼成液体油,冷却后用离心机或分离机除去水分和残渣。
(1)将聚乙二醇400溶剂水浴加热至100℃,在搅拌状态下依次加入十一烯酸和十一烯酸锌,旱獭油、全蝎、蜈蚣、凡士林溶液。
(2)将溶液(1)冷却至20~30℃,加入硅酸铝镁和双甲氨基月桂乙酯、冰片、梅片高速离心搅拌1h,制成混悬液,在胶体磨中混匀进行细化处理,细化液再置于均质机中再进行进一步混匀细化,即纳米化粉碎,制成粒径在0.1-2μm的天然动植物纳米乳液。这种纳米化乳液产品保持了天然动植物功效和全部营养成分,所以乳膏中的功效营养成分更齐全。疗效更佳这种脚气灵纳米乳膏具有良好的渗透性能、渗透速度快,吸收效果好。
本发明充分例用家庭养殖动物资源使用方便,疗效显著,无毒副作用及刺激性,无药物不良反应,用后皮肤细腻光滑。
双甲氨基月桂乙酯是皮肤渗透增强剂,在0.5%~40%的浓度下可以溶解皮肤以及粘膜组织上皮细胞间隙的脂肪微粒,使药物通过细胞间隙透至相关组织,由于它并不对皮肤角质层和上皮细胞产生作用,因此不会损伤皮肤和粘膜上皮。
聚乙二醇400是非离子型惰性溶剂,在100℃的高温下可以完全溶解十一稀酸及其锌盐,并且在常温下保持稳定,不会和透皮剂等活性物质发生反应而影响效果。
硅酸铝镁为增稠和稳定剂,配伍性好,有较好的增稠性、扩散性、悬浮性及持水保湿性能,并具有一定的抗热能力和热稳定性。
本品为抗真菌感染的天然动植物药制剂,主要用于治疗足癣脚臭。真菌感染类皮肤病。
使用方法:将患处洗净,均匀涂抹本品,充分揉搓。第1次连续用药3天后停药如一周后未痊愈可连续再用3天,适每晚临睡前洗脚后用药。
本品的创新性在于用天然动植物药的纳米粉碎技术皮肤渗透增强剂与十一烯酸及能滤毒吸毒离子交换的沸石纳米粉和锌盐配合,形成新型的抗皮肤真菌药物,能够以高于传统疗法用药5~6倍的速度通过上皮屏障达到病灶,疗效显著持久,愈后不复发;本品配方科学,无毒副作用及过敏现象,对皮肤无刺激,并且无异味,使用安全方便。
2、一种脚气灵纳米乳膏,其特征是:所述木槿皮蜂胶用于手足股体癣杀菌止痒乳膏,按下列质量份配比组成%
制备方法
将水杨酸、苯甲酸、升华硫、硼酸、滑石粉、淀粉、苦参、蝉蜕、木槿皮、蜂胶破碎研细,过2500~3000目筛,中心粒径为0.1-2μm的纳米小分子然后再将蜂王浆、薄荷油、灰黄霉素(0.1g片剂)放入95%医用乙醇中充分搅拌均匀,密封3d,即可装瓶。
蜂胶含有黄酮化合物、不低于46种有酸类、酯类、醇类、醛、酮、酚、醚等二十多种生物学活性的有机化合物和多种宏微元素,是“天然的广谱抗菌剂”能有效的杀菌抑菌、是天然“免疫增强剂”;蜂王浆含有多种激素,尤其含有10-羚基-2葵烯酸成分;苦参有清热燥湿杀虫和滋养皮肤的功效;蝉蜕具有散风热、去搔痒的作用;薄荷油镇痛效果好;灰黄霉素杀灭真菌效果显著。
本品具有抗菌消炎、去湿止痒、防止真菌感染、排毒除湿、消炎生肌功效,是用于治疗脚癣(脚气),除此以外,对凡属真菌感染的皮肤病如手癣、头癣、体癣、股癣均有很好疗效,同时可保养皮肤。
使用方法:先将患部洗净擦干,再用棉球蘸药涂在患处,早晚各1次,连续使用3~5天可彻底治愈。
本品工艺简单,配方合理,起效迅速,疗程短,效果显著持久,不易复发。
3、一种脚气灵纳米乳膏,其特征是,所述硫磺大黄杀菌除湿化腐生肌除脚气乳膏,按下列质量份配比组成%
制备方法
(1)将冰片溶于乙醇溶液。
(2)将乳香、薄荷研末后液化。
(3)将白矾、硫磺、雄黄分别研极细后混合均匀。
(4)将薄荷、大黄热煎后提取浓缩液。
(5)将麝香、阿司匹林加入二甲基亚砜研磨成细粉将上述物充分混合制成混悬液,再在均质机中进行混合细化,再进行纳米化粉碎制成粒径在0.1-2μm的纳米乳液,再加入凡士林升温80~85℃充分搅匀冷却后分装。
本品具有消炎镇痛、杀菌抑菌、祛风除湿、化腐生肌、护肤肌肤等功效,主要用于治疗脚气。将中西医有机结合,运用现代的纳米技术,用药简单量少;见效快,治愈率高,远期疗效好,停药后不复发;无毒副作用无过敏现象,安全可靠。见效快,效果显著持久,使用时,将本品涂抹在患处即可。
4、一种脚气纳米乳膏,其特征是:所述斑蝥密陀僧解毒润燥杀虫止痒治顽癣足癣乳膏,按下列质量份配比组成%
制备方法
(1)将以上各原料进行筛选、称量。
(2)将丹余、煅牡蛎、枯矾、煅膏、龙脑、水龙骨、斑蝥、硫磺、密陀僧、三仙丹固态药用超细微纳米粉碎研磨至极细,并与水杨酸粉、滑石粉、钛白粉3种药物搅拌混合均匀用纳米级粒径超细微化装置处理的过2200-3000目筛,中心粒径为0.1-2μm的纳米小分子的纳米粉。
(3)向物料(2)中加入蛇油(或甘油),搅拌调匀成稠膏。
(4)将天然中药苦参、蛇床子、地肤子、甘草粉碎成60目的粗粉,加8倍的水制成混悬液,用均质乳化机进行均匀细化;细化液再用纳米级粒径超细微化装置制成粒径为0.1-2μm的纳米化乳液。
(5)将稠膏(3)与纳米化乳液(4)调稀至糊状,然后装袋封口即为成品。
本品具有追风祛湿、清热解毒、杀菌杀虫消炎、活血生肌等功效,不仅适用于脚气(足癣)患者,还可用于手癣、体癣、股癣、花斑癣的治疗。用其治疗顽癣有良效。
使用方法:先洗净手脚患处、用药棉蘸药膏均匀地涂抹于患处,每日2~3次,直至痊愈为止。
本品见效快,效果好,远期疗效稳定,不易复发;无毒副作用及不良反应,愈后无疤痕,安全可靠。
5.一种脚气灵纳米乳膏,其特征是,所述川楝皮海桐皮用于久治不愈的顽癣手足癣乳膏,按下列质量份配比组成%
制备方法:
将川槿皮、海桐皮、大黄、巴豆去油、斑蝥、雄黄、轻粉、水杨酸、苯甲酸、升华硫、硼酸、滑石粉、枯矾、淀粉破碎研细,过2200-3000目筛中心粒径为0.1~2μm的纳米小分子然后再加入蛇油、凡士林升温加热至80℃充分搅拌混合,即得纳米乳膏。
本品具有抗菌消炎,去湿止痒、防止真菌感染之功效,用于治疗顽癣手足癣。使用时将本品涂于患处,早晚各一次。
本品工艺简单,配方合理,起效迅速,疗程短,效果显著持久,不易复发。
下面结合实施例子对本发明进一步阐明:
具体实施方法:
实施例1、一种脚气灵纳米乳膏,其特征是,所述旱獭油蜈蚣用于脚气脚臭类皮肤病乳膏,按下列质量份配比组成%
实施例2、一种脚气灵纳米乳膏,其特征是:所述木槿皮蜂胶用于手足股体癣杀菌止痒乳膏,按下列质量份配比组成%
实施例3、一种脚气灵纳米乳膏,其特征是,所述硫磺大黄杀菌除湿化腐生肌除脚气乳膏,按下列质量份配比组成%
实施例4、一种脚气纳米乳膏,其特征是:所述斑蝥密陀僧解毒润燥杀虫止痒治顽癣足癣乳膏,按下列质量份配比组成%
实施例5、一种脚气灵纳米乳膏,其特征是,所述川楝皮海桐皮用于久治不愈的顽癣手足癣乳膏,按下列质量份配比组成%
Claims (5)
1.一种脚气灵纳米乳膏,其特征是,所述旱獭油蜈蚣用于脚气脚臭类皮肤病乳膏,按下列质量份配比组成%
2.一种脚气灵纳米乳膏,其特征是:所述木槿皮蜂胶用于手足股体癣杀菌止痒乳膏,按下列质量份配比组成%
3.一种脚气灵纳米乳膏,其特征是,所述硫磺大黄杀菌除湿化腐生肌除脚气乳膏,按下列质量份配比组成%
4.一种脚气纳米乳膏,其特征是:所述斑蝥密陀僧解毒润燥杀虫止痒治顽癣足癣乳膏,按下列质量份配比组成%
5.一种脚气灵纳米乳膏,其特征是,所述川楝皮海桐皮用于久治不愈的顽癣手足癣乳膏,按下列质量份配比组成%
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710165313.6A CN107050059A (zh) | 2017-03-13 | 2017-03-13 | 脚气灵纳米乳膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710165313.6A CN107050059A (zh) | 2017-03-13 | 2017-03-13 | 脚气灵纳米乳膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107050059A true CN107050059A (zh) | 2017-08-18 |
Family
ID=59620591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710165313.6A Withdrawn CN107050059A (zh) | 2017-03-13 | 2017-03-13 | 脚气灵纳米乳膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107050059A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108403758A (zh) * | 2018-05-10 | 2018-08-17 | 梁玉华 | 去脚气膏及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103223095A (zh) * | 2013-04-28 | 2013-07-31 | 王树庆 | 一种治疗脚气的药膏 |
CN104352738A (zh) * | 2014-11-20 | 2015-02-18 | 樊秀英 | 一种治疗脚气的药膏 |
CN104906203A (zh) * | 2015-04-24 | 2015-09-16 | 南通蛇类治疗研究所 | 治手足癣无痛性纳米乳膏 |
-
2017
- 2017-03-13 CN CN201710165313.6A patent/CN107050059A/zh not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103223095A (zh) * | 2013-04-28 | 2013-07-31 | 王树庆 | 一种治疗脚气的药膏 |
CN104352738A (zh) * | 2014-11-20 | 2015-02-18 | 樊秀英 | 一种治疗脚气的药膏 |
CN104906203A (zh) * | 2015-04-24 | 2015-09-16 | 南通蛇类治疗研究所 | 治手足癣无痛性纳米乳膏 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108403758A (zh) * | 2018-05-10 | 2018-08-17 | 梁玉华 | 去脚气膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110256245A1 (en) | Methods and compositions of cannabis extracts | |
WO2008140200A1 (en) | External compositions for the skin | |
CN1768841A (zh) | 一种治疗皮肤病的中药复方制剂 | |
CN104906203A (zh) | 治手足癣无痛性纳米乳膏 | |
CN105779175A (zh) | 一种具有祛痘功能的天然手工皂及其制备方法 | |
CN102114166A (zh) | 一种中药膏及其制作方法 | |
CN105534792A (zh) | 一种含有纳米钻石烯的中草药牙膏 | |
CN102755573A (zh) | 一种治疗灰指甲的外用中药 | |
CN107050059A (zh) | 脚气灵纳米乳膏 | |
CN104147584A (zh) | 一种治疗脚气的药物及其制作方法 | |
CN1772127A (zh) | 七味解毒活血膏及其制备方法 | |
CN101766697A (zh) | 一种抗真菌治疗皮肤癣疾的药物及其制备方法 | |
CN106860188A (zh) | 美容润肤纳米乳霜 | |
CN1090961C (zh) | 灰指甲膏的制备方法 | |
CN101912450A (zh) | 一种治疗脚气皮炎的中西药组合物及其制备方法 | |
JP2000273046A (ja) | 皮膚疾患治療薬 | |
CN104289294A (zh) | 一种中药生产方法 | |
CN1435225A (zh) | 治疗脚气的足癣消药膏 | |
CN101332283B (zh) | 一种治疗狐臭的喷剂药物 | |
CN107802734A (zh) | 植物纳米癣湿水 | |
CN109925368A (zh) | 一种抑菌防足癣的护肤去角质膏 | |
CN106938024A (zh) | 消银纳米乳膏 | |
WO2023052393A1 (de) | Mechanochemisch vorbehandelte, schwermetallfreie aktivkohlepartikel a, topische arzneimittel, medizinprodukte und kosmetika, herstellverfahren und verwendungen | |
CN101711842B (zh) | 一种纯中药消炎止痒液及其制法 | |
CN103751572A (zh) | 除脚气喷剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170818 |